Login to Your Account



Hot Dermatology Space Gains New Player in Start-up Aclaris

By Jennifer Boggs
Managing Editor

Friday, November 16, 2012
As a handful of global pharma firms vie for bigger portions of the increasingly popular dermatology market, a new entrant entered the space earlier this year: Aclaris Therapeutics Inc., which launched with a $21 million Series A round to advance its lead topical dermatology program into clinical testing.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription